Finding ways to bring therapeutic proteins to market faster is an ongoing challenge for global pharmaceutical development. Of all the analytical methods to be developed, charge variant analysis methods, used to monitor post-translational modifications (PTMs), generally require the longest development time.

 

Join Peter Holper from SCIEX to discover a new approach to finding a robust, stability indicating charge variant method. Using a widely universal buffer, this technique requires little to no method development, has a simple sample preparation, analyzes a molecule in its native state, and has a higher analytical throughput than IEX or icIEF. 

 

Learning Objectives: